This app wants to help truckers get healthy
Did you know that out of the 3.5 million truckers working in the U.S., more than two thirds have obesity? Shocking, right? Truck drivers are at a higher risk of developing type 2 diabetes compared to the general population and unfortunately, on average, they die at just 61 years old. But there’s hope on the horizon!
Enter Offshift, a digital health app and coaching program specifically designed to help truckers improve their health. The program offers tailored advice for truckers, focusing on eating tips based on the food available roadside and exercise routines that can be done in tight spaces with limited breaks. It’s part of a larger group of programs aimed at helping users lead a healthier lifestyle to prevent or manage chronic diseases.
One couple, Steve and Gina Jones, have recently started working with a coach through Offshift. Gina shared a clever hack she uses while on the road – using an exercise step inside the truck while Steve fuels up. She mentioned, “The truck’s rocking and the antennas are moving, and I’m sure they’re thinking, ‘What’s going on!?'”. To learn more about why most truckers struggle with their health and the challenges Offshift faces, read the full story from STAT’s Katie Palmer.
74,000
A recent report published in JAMA Internal Medicine revealed that NIH funding cuts have impacted over 74,000 individuals who were enrolled in various experiments. Between the end of February and mid-August, 383 studies lost their funding, affecting research on treatments for conditions such as cancer, heart disease, and brain disease. The implications of these funding cuts are significant and could have long-lasting effects on medical research. For more information, check out the full report.
Why vaccine makers are worried about removing aluminum
The landscape of American vaccine policy is on the verge of a major shift as leaders in the Trump administration consider two proposals that could impact vaccine safety and efficacy. One proposal suggests breaking up the measles-mumps-rubella combination shot into three separate vaccines, while the other aims to remove aluminum from vaccines that currently contain it. These changes could have far-reaching consequences for vaccine makers, potentially requiring them to develop alternative vaccines at a significant cost and time investment.
According to employees at vaccine companies who spoke with STAT’s Daniel Payne, these changes could disrupt a substantial portion of the U.S. childhood vaccine schedule. The potential fallout from these proposals is concerning, and stakeholders are closely monitoring the situation. For more insights from industry insiders on the implications of these proposed changes, read the full article.
Inside Kennedy’s rise at HHS
Health Secretary Robert F. Kennedy Jr. wasted no time in shaking up federal health policy upon taking office. In his first hours, he outlined his priorities for reform on a whiteboard, signaling a significant departure from the status quo. Kennedy’s leadership style and ambitious agenda have captivated supporters and alarmed critics alike, making him a central figure in the Trump administration’s health and science initiatives.
Through extensive interviews with individuals in Kennedy’s inner circle, including nine individuals close to him, STAT reporters uncovered exclusive details about his management approach, relationship with the president, and motivations for spearheading sweeping changes in health policy. Despite the challenges of accessing sources within Kennedy’s circle, the reporters managed to shed light on his leadership style and decision-making processes.
Discover why Kennedy’s aides prefer to sit on the ground during his calls with the president and learn more about his unconventional approach to governance in the full story.
A case study on cravings and a GLP-1
Recent research published in Nature Medicine delves into the potential of GLP-1 medications to address impulse control and addiction. In a compelling case study, researchers explored the effects of tirzepatide on a 60-year-old woman struggling with obsessive thoughts about food and overeating. Despite previous interventions like bariatric surgery and behavioral therapy, the patient found relief with tirzepatide, which temporarily suppressed signaling in the brain’s reward center.
This groundbreaking study offers a glimpse into the complex relationship between brain activity and cravings, highlighting the potential of GLP-1 medications in managing conditions related to impulse control. While more research is needed to validate these findings, the study provides valuable insights into the role of these medications in addressing addictive behaviors.
What we’re reading
-
Abortion opponents are targeting IVF clinics in a bid to promote fertility clinics, as reported by The 19th
-
Dementia housing without locked wards is a growing trend, explored in a piece by NPR
- FDA clears spinal cord stimulator for home use, as covered by STAT
- ICE’s presence at hospital bedsides raises concerns about detainee rights, detailed by KFF Health News
- Analysis reveals that many poor countries benefit little from experimental drug testing post-approval, as highlighted in a piece by STAT
